Drug Markets/Cetrorelix Acetate

Cetrorelix Acetate

1 NDC across 1 manufacturer|0 Generic,1 Brand

Cetrorelix Acetate is used to treat ovarian hyperstimulation syndrome, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Aug 11, 2000, and the first generic was approved Aug 12, 2022.

Cetrorelix Acetate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $306.06 to $306.06 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$306.06 – $306.06

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing CETRORELIX ACETATE

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
CETROTIDE 0.25 MG VIAL
$306.0574
per EA
—

Frequently Asked Questions

What is Cetrorelix Acetate used to treat?

Cetrorelix Acetate is used to treat ovarian hyperstimulation syndrome, per the National Library of Medicine's MED-RT classification.

When did Cetrorelix Acetate become available as a generic?

FDA approved the first generic Cetrorelix Acetate (ANDA) on Aug 12, 2022.

How many Cetrorelix Acetate products are on the market?

The Cetrorelix Acetate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Cetrorelix Acetate?

NADAC reference prices for Cetrorelix Acetate range from $306.0574 to $306.0574 per EA.

Which manufacturers make Cetrorelix Acetate?

1 manufacturer lists Cetrorelix Acetate in NADAC. Ranked by number of NDCs, the largest are EMD Serono, Inc. (1).